ANI Pharmaceuticals Inc. (ANIP)
59.77
-0.22 (-0.37%)
At close: Feb 20, 2025, 3:59 PM
59.67
-0.17%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 58.35 |
| Market Cap | 1.26B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.47 |
| PE Ratio (ttm) | -127.17 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 61.07 |
| Volume | 116,311 |
| Avg. Volume (20D) | 224,893 |
| Open | 59.86 |
| Previous Close | 59.99 |
| Day's Range | 58.84 - 60.41 |
| 52-Week Range | 52.50 - 70.81 |
| Beta | undefined |
About ANIP
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development a...
Full Company ProfileAnalyst Forecast
According to 7 analyst ratings, the average rating for ANIP stock is "Buy." The 12-month stock price forecast is $78.5, which is an increase of 31.34% from the latest price.
Buy 85.71%
Hold 14.29%
Sell 0.00%
Next Earnings Release
ANI Pharmaceuticals Inc. is scheduled to release its earnings on Feb 28, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
-9.92%
ANI Pharmaceuticals shares are trading lower after...
Unlock content with
Pro Subscription
6 months ago
+6.98%
ANI Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 guidance.
